EICOSANOIDS AND INFLAMMATION

EICOSANOIDS AND INFLAMMATION

Inflammation is the most important element in the pathogenesis of major human diseases. It determines the fundamental value of anti-inflammatory therapy in the modern concept of targeted pathogenetic treatment. The rational choice of anti-inflammatory drugs and the design of new promising agents are...

Full description

Bibliographic Details
Main Authors:	A. E. Karateev, T. L. Aleinikova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2016-12-01
Series:	Современная ревматология
Subjects:	inflammation eicosanoids cyclooxygenase 2 5-lipoxygenase microsomal pge2-synthase prostaglandins leukotrienes auxins hepoxilins lipoxins epoxyeicosatrienoic acid resolvins protectins maresin endocannabinoids nonsteroidal anti-inflammatory drugs oxicams
Online Access:	https://mrj.ima-press.net/mrj/article/view/723

Similar Items

Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection
by: Anandita Pal, et al.
Published: (2020-08-01)

Resolution of Inflammation after Skeletal Muscle Ischemia–Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins
by: Cindy Barnig, et al.
Published: (2022-06-01)

Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
by: Kristin Grotle Nore, et al.
Published: (2020-11-01)

Polyunsaturated fatty acid-derived lipid mediators and T cell function
by: Anna eNicolaou, et al.
Published: (2014-02-01)

Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications
by: Mariarosaria Valente, et al.
Published: (2022-07-01)

Pharmacological effects of specialized pro-resolving mediators in sepsis-induced organ dysfunction: a narrative review
by: Shujun Sun, et al.
Published: (2024-09-01)

Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease
by: Jesmond Dalli, et al.
Published: (2022-02-01)

Knock-In Mice Expressing a 15-Lipoxygenating Alox5 Mutant Respond Differently to Experimental Inflammation Than Reported <i>Alox5<sup>−/−</sup></i> Mice
by: Eugenia Marbach-Breitrück, et al.
Published: (2021-10-01)

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
by: Nils Helge Schebb, et al.
Published: (2022-03-01)

Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation
by: Inês Ferreira, et al.
Published: (2022-03-01)

Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis
by: Carlos A. M. Silva, et al.
Published: (2018-02-01)

Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation
by: Charles N Serhan, et al.
Published: (2012-10-01)

Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation
by: Charles N. Serhan, et al.
Published: (2024-09-01)

Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control
by: Rodrigo A. López-Muñoz, et al.
Published: (2018-08-01)

On the cellular metabolism of the click chemistry probe 19-alkyne arachidonic acid[S]
by: Philippe Pierre Robichaud, et al.
Published: (2016-10-01)

Eicosanoids and cancer
by: Renata Nascimento Gomes, et al.
Published: (2018-08-01)

Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations[S]
by: Susanna L. Lundström, et al.
Published: (2013-01-01)

Omega fatty acids and resolution of inflammation: A new twist in an old tale
by: Mittal Antush, et al.
Published: (2010-01-01)

Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation
by: Gyeoung Jin Kang, et al.
Published: (2020-12-01)

Infection, Inflammation, and Immunity in Sepsis
by: Undurti N. Das
Published: (2023-08-01)

The potential role of n-3 fatty acids and their lipid mediators on asthmatic airway inflammation
by: Yuan Tian, et al.
Published: (2024-12-01)

Lipoxins as biomarkers of lupus and other inflammatory conditions
by: Das Undurti N
Published: (2011-05-01)

The Role of Eicosanoids in Gynecological Malignancies
by: Paige G. Smith, et al.
Published: (2020-08-01)

Omega 3 Fatty Acid and Skin Diseases
by: Yu Sawada, et al.
Published: (2021-02-01)

The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders
by: Juliette Giacobbe, et al.
Published: (2020-02-01)

Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections
by: Undurti N. Das
Published: (2021-04-01)

Métabolisme oxygéné des acides gras polyinsaturés et fonction dans les cellules sanguines et vasculaires1
by: Lagarde Michel
Published: (2011-03-01)

Eicosanoids: physiology update and orthodontic implications
by: Collett Anthony R., et al.
Published: (1991-10-01)

Eicosanoid Control Over Antigen Presenting Cells in Asthma
by: Nincy Debeuf, et al.
Published: (2018-09-01)

BCG vaccination is associated with longitudinal changes in systemic eicosanoid levels in elderly individuals: A secondary outcome analysis
by: Pavan Kumar Nathella, et al.
Published: (2024-06-01)

Deuterated Arachidonic Acids Library for Regulation of Inflammation and Controlled Synthesis of Eicosanoids: An In Vitro Study
by: Dmitry V. Chistyakov, et al.
Published: (2018-12-01)

Metabolic pathways of eicosanoids—derivatives of arachidonic acid and their significance in skin
by: Michał Biernacki, et al.
Published: (2025-01-01)

Eicosanoids and Oxidative Stress in Diabetic Retinopathy
by: Mong-Heng Wang, et al.
Published: (2020-06-01)

Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo
by: Luigia Di Francesco, et al.
Published: (2020-04-01)

ALOX5 gene variants affect eicosanoid production and response to fish oil supplementation[S]
by: Charles B. Stephensen, et al.
Published: (2011-05-01)

Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?
by: Undurti N. Das, et al.
Published: (2017-08-01)

Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners
by: Anne-Sophie Archambault, et al.
Published: (2022-01-01)

Cytoplasmic lipid bodies in eosinophils: Central roles in eicosanoid generation
by: Peter F Weller, et al.
Published: (1997-01-01)

Functional characterization of genetic enzyme variations in human lipoxygenases
by: Thomas Horn, et al.
Published: (2013-01-01)

Ginkgolic Acid is a Multi-Target Inhibitor of Key Enzymes in Pro-Inflammatory Lipid Mediator Biosynthesis
by: Jana Gerstmeier, et al.
Published: (2019-07-01)